Associate Professor Microbiology and Immunology, Laboratory of Virus Host Interaction, Division of Basic Science
The laboratory of virus-host interactions has taken the approach to study viral pathogenesis to inform therapeutic approaches. In particular, studies on the effect of human beta-defensins have yielded important information on cells populations that are highly susceptible to HIV infection. That information can now be used to design novel therapeutics. A second study on “retrocyclin” defensins, which are not expressed in humans, confirms that defensins have anti-inflammatory activities, and hold promise as therapeutics against emerging pathogens.
Location: RB101, CVM, NC State University
Time: Tuesday, September 20, 2017, 4:00- 5:00 pm